Neos Therapeutics Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Neos Therapeutics (NEOS) Misses Q2 EPS by 8c, Revenues Miss
August 8, 2018 7:15 AM EDTNeos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($0.52), $0.08 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $11.36 million versus the consensus estimate of $12.1 million.
Second quarter revenues for our ADHD products were $10.8 million which represents a 22.5% growth over first quarter... More
